11/16/20

NOBIC Client Chosen Diagnostics’ Device Authorized as Breakthrough

Chosen Diagnostics’ NECDetect for Preterm Babies Authorized as Breakthrough Device by FDA NEW ORLEANS, LA. (Nov. 16, 2020) — Chosen Diagnostics is pleased to announce that the US Food &…


09/17/20

MAJOR NEWS: NOBIC wins $1.5M EDA Award

New Orleans BioInnovation Center Awarded $1.5 Million Grant from U.S. EDA Incubator anticipates creating or retaining 650 jobs and attracting $75 million in private capital NEW ORLEANS (Sep. 17, 2020)…


08/04/20

COVID-19 Innovation Showcase: Summary & Outcomes

COVID-19 Southeast Innovation Showcase NOBIC partnered with the Biomedical Advanced Research and Development Authority (BARDA), Biolocity (Atlanta, GA), and First Flight Venture Center (Research Triangle, NC), to host this unique…


01/17/19

BARDA Announces Interagency Group to Battle Opioid Epidemic

The Biomedical Advanced Research and Development Authority (BARDA) is leading an interagency group to develop a wearable device to detect, and possibly treat, an opioid overdose.  This group, Technology Innovation…